Big Pharma partnerships, record $22.7B investment raise profile of regenerative medicine in 2021

Regenerative medicine couldn't stop making news in 2021. The year was marked by Intellia's first results in humans for gene editing, massive Big Pharma partnerships and record investment of $22.7 billion.